Interestingly, Hippo pathway deregulation in cancer has been shown to drive FOXM1 activation through YAP–TEAD-dependent FOXM1 transcription, while FOXM1 additionally interacts directly with TEAD on target gene promoters, contributing to cell proliferation and tumor development [71]. The gene discussed is FOXM1; the disease is cancer.